Evidence map›Paper›PMID 36328130›Full record

ArticleActa biomaterialia2023

Mesenchymal stromal cell spheroids in sulfated alginate enhance muscle regeneration.

Marissa A Gionet-Gonzales, Robert C H Gresham, Katherine H Griffin, Alena Casella, Ross P Wohlgemuth, David H Ramos-Rodriguez, Jeremy Lowen, Lucas R Smith, J Kent Leach

Open access · hybridAbstract read
In one paragraph

Article in Acta biomaterialia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Edible Sulfonated Soy Protein Microcarriers for Cultivated Meat Cell Expansion.Journal of biomedical materials research. Part A · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Marissa A Gionet-GonzalesDepartment of Orthopaedic Surgery, School of Medicine, UC Davis Health, Sacramento, CA, USA.
Robert C H GreshamDepartment of Orthopaedic Surgery, School of Medicine, UC Davis Health, Sacramento, CA, USA.
Katherine H GriffinDepartment of Orthopaedic Surgery, School of Medicine, UC Davis Health, Sacramento, CA, USA; School of Veterinary Medicine, UC Davis, Davis, CA, USA.
Alena CasellaDepartment of Orthopaedic Surgery, School of Medicine, UC Davis Health, Sacramento, CA, USA.
Ross P WohlgemuthDepartment of Neurobiology, Physiology and Behavior, UC Davis, Davis, CA, USA.
David H Ramos-RodriguezDepartment of Orthopaedic Surgery, School of Medicine, UC Davis Health, Sacramento, CA, USA.
Jeremy LowenDepartment of Orthopaedic Surgery, School of Medicine, UC Davis Health, Sacramento, CA, USA.
Lucas R SmithDepartment of Neurobiology, Physiology and Behavior, UC Davis, Davis, CA, USA; Department of Physical Medicine and Rehabilitation, UC Davis Health, Sacramento, CA, USA.
J Kent LeachDepartment of Orthopaedic Surgery, School of Medicine, UC Davis Health, Sacramento, CA, USA; Department of Biomedical Engineering, UC Davis, Davis, CA, USA. Electronic address: jkleach@ucdavis.edu.
University of California, Davis · USUC Davis Health · US

Funding

Identifying the superior ossification pathway for tissue engineered approaches to long bone repairR01AR079211 · NIAMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LEACH, J. KENT · 2021 to 2025
$1.9M
Biomaterial regulation of cell spheroids to synergistically enhance bone healingR01DE025475 · NIDCR · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LEACH, J. KENT · 2015 to 2019
$1.9M
NIAMS NIH HHS R01 AR079211NIDCR NIH HHS R01 DE025475
6 · The paper itself

Abstract

The therapeutic efficacy of mesenchymal stromal cells (MSCs) for tissue regeneration is critically linked to the potency of the complex mixture of growth factors, cytokines, exosomes, and other biological cues that they secrete. The duration of cell-based approaches is limited by rapid loss of cells upon implantation, motivating the need to prolong cell viability and extend the therapeutic influence of the secretome. We and others demonstrated that the secretome is upregulated when MSCs are formed into spheroids. Although the efficacy of the MSC secretome has been characterized in the literature, no studies have reported the therapeutic benefit of in situ sequestration of the secretome within a wound site using engineered biomaterials. We previously demonstrated the capacity of sulfated alginate hydrogels to sequester components of the MSC secretome for prolonged presentation in vitro, yet the efficacy of this platform has not been evaluated in vivo. In this study, we used sulfated alginate hydrogels loaded with MSC spheroids to aid in the regeneration of a rat muscle crush injury. We hypothesized that the use of sulfated alginate to bind therapeutically relevant growth factors from the MSC spheroid secretome would enhance muscle regeneration by recruiting host cells into the tissue site. The combination of sulfated alginate and MSC spheroids resulted in decreased collagen deposition, improved myogenic marker expression, and increased neuromuscular junctions 2 weeks after injury. These data indicate that MSC spheroids delivered in sulfated alginate represent a promising approach for decreased fibrosis and increased functional regeneration of muscle. STATEMENT OF SIGNIFICANCE: The therapeutic efficacy of mesenchymal stromal cells (MSCs) for tissue regeneration is attributed to the complex diversity of the secretome. Cell-based approaches are limited by rapid cell death, motivating the need to extend the availability of the secretome. We previously demonstrated that sulfated alginate hydrogels sequester components of the MSC secretome for prolonged presentation in vitro, yet no studies have reported the in situ sequestration of the secretome. Herein, we transplanted MSC spheroids in sulfated alginate hydrogels to promote muscle regeneration. MSC spheroids in sulfated alginate decreased collagen deposition, improved myogenic marker expression, and increased neuromuscular junctions. These data indicate that MSC spheroids delivered in sulfated alginate represent a promising approach for decreasing fibrosis and increasing functional muscle regeneration.

Indexed as

Mesenchymal Stem CellsSpheroids, CellularAlginatesAnimalsCollagenHydrogelsMusclesRatsSulfatesAlginatesCollagenHydrogelsSulfatesInnervationMesenchymal stromal cellsMuscleSecretomeSulfated hydrogel

Identifiers

PMID36328130
PMCPMC11970561
OpenAlexW4307739787

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.